Alexandria Venture Investments
Description
Alexandria Venture Investments is the strategic venture capital arm of Alexandria Real Estate Equities, Inc. (ARE), a leading urban office REIT focused on collaborative life science, agrifoodtech, and technology campuses. Leveraging its parent company's extensive real estate and scientific ecosystem, Alexandria Venture Investments provides strategic capital to innovative companies across the life science, agrifoodtech, clean energy, and advanced technology sectors. Their unique position allows them to offer not only financial investment but also access to ARE's vast network, specialized infrastructure, and deep industry expertise, fostering the growth and success of their portfolio companies.
The firm's investment strategy is comprehensive, spanning the entire lifecycle of companies from seed-stage startups to those approaching an IPO. They are known for their long-term partnership approach, often supporting companies through multiple funding rounds. Beyond capital, Alexandria Venture Investments actively assists portfolio companies with critical resources, including access to state-of-the-art laboratory and office space, scientific advisory boards, and opportunities for collaboration within Alexandria's vibrant tenant community. This integrated approach aims to accelerate the development and commercialization of groundbreaking technologies.
Alexandria Venture Investments has established itself as a significant player in the venture capital landscape, demonstrating a robust and consistent investment track record. To date, they have invested over $2.9 billion across more than 800 companies, showcasing their extensive reach and commitment to fostering innovation in their core sectors. Their portfolio includes a diverse range of companies, from novel therapeutic developers and diagnostic innovators to leaders in sustainable agriculture and cutting-edge technology solutions. This deep engagement underscores their role as a crucial enabler of scientific and technological advancement.
Investor Profile
Alexandria Venture Investments has backed more than 280 startups, with 31 new investments in the last 12 months alone. The firm has led 16 rounds, about 6% of its total and boasts 51 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Series C rounds (top funding stages).
- Majority of deals are located in United States, France, Canada.
- Strong thematic focus on Biotechnology, Health Care, Therapeutics.
- Led 2 rounds in the past year.
- Typical check size: $1M – $20M.
Stage Focus
- Series A (39%)
- Series B (26%)
- Series C (12%)
- Seed (10%)
- Series Unknown (5%)
- Post Ipo Equity (2%)
- Series D (2%)
- Convertible Note (2%)
- Series E (1%)
Country Focus
- United States (95%)
- France (2%)
- Canada (2%)
- Switzerland (1%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Medical
- Life Science
- Pharmaceutical
- Biopharma
- Genetics
- Oncology
- Health Diagnostics
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Alexandria Venture Investments frequently co-invest with?
Which angels does Alexandria Venture Investments often collaborate with?
What are some of recent deals done by Alexandria Venture Investments?
Find More Investors Like Alexandria Venture Investments
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
